The cumulative COVID-19 vaccine doses administered in the country has exceeded 101.30 crore,
Earlier, Adar Poonawalla had said clinical trials of COVID-19 vaccine Covovax have begun in India
Speedy permissions granted by the government authorities made the development of the coronavirus
Mandaviya was speaking amid a din in the house over the Opposition's demand for a discussion on the
The approval comes at a time when Covishield has been omitted by the European Medicines Agency
In March this year, he had said that the clinical trials of Covovax vaccine have begun in India and
The Novavax vaccine uses purified pieces of coronavirus rather than mRNA.
The Novavax vaccine, which is easy to store and transport, is expected to play an important role in
This development comes days after Centre announced fresh Covid vaccine procurement guidelines
According to the four conditions set by the DCGI, the Serum Institute will have to submit a copy of
Serum Institute has already informed the government that it will be able to manufacture and supply
Indian Businessman, Philanthropist, vaccine maker popularly known as India's 'Vaccine Prince' is
Covishield and Bharat Biotech's Covaxin were the first two COVID-19 vaccines to be granted approval
The Serum Institute had on March 23 sought permission from the ministry to supply 50 lakh doses of
"Everything falls on my shoulders but I can't do it alone", said Adar Poonawalla in his interview.
Tamil Nadu Health Secretary has said the state government has ordered for 1.5 crore vaccines.
Karnataka Health Minister Dr K Sudhakar asked people who have enrolled themselves on the Cowin
Many states have objected to different prices of the vaccines, with Delhi Chief Minister Arvind
Vaccine maker Serum Institute of India (SII) today defended pricing Covishield vaccine at 1.5 times